<DOC>
	<DOCNO>NCT02823236</DOCNO>
	<brief_summary>The aim study assess efficacy safety combination intralesional triamcinolone ( dose 4mg / cm2 interval 4 week ) topical pirfenidone 8 % ( every 8 hour continuously ) compare isolated application , treatment keloid scar adult . The duration three-arm clinical trial 12 month , 6-month period treatment follow-up 6 month assess recurrence . The estimated number person recruit randomize study 102 .</brief_summary>
	<brief_title>Efficacy Intralesional Triamcinolone 8 % Topical Pirfenidone Treatment Keloid Scars</brief_title>
	<detailed_description>Individuals keloid scar randomize 3 arm treatment order ass efficacy combine intralesional triamcinolone topical pirfenidone compare isolated application drug . The intervention last 6 month individual assess monthly determine recurrence 6 month . The scar size measure week 12 , 24 52 .</detailed_description>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Keloids size equal major 1 cm Keloids le 5 year old Keloids trunk Keloid surgical indication Hypertrophic scar Scars burn wound Pregnancy Lactation Use systemic chemotherapeutics chronic use systemic corticosteroid immunosuppressive medication Known hypersensitivity triamcinolone pirfenidone Severe comorbidity control Inflammatory acne Diabetes Mellitus Hypertension Renal , hepatic respiratory failure Topical treatment 4 week recruitment Previous treatment intralesional steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Keloid</keyword>
	<keyword>Scar</keyword>
</DOC>